日本护士╳╳╳HD少妇,国产精品久久久久久久久鸭无码,国产二区交换配乱婬,日本护士╳╳╳HD少妇

News Express

2025-04-16

The Shanghai Conference on Promoting High Quality Development of Private Economy was grandly held, and Chairman Xu Honglei was invited to attend

Recently, the Shanghai Conference on Promoting High Quality Development of Private Economy was grandly held. Xu Honglei, Chairman of Shanghai Chaorui Group/Suzhou Siyao, and representatives from nearly a hundred private enterprises were invited to attend the conference and discuss development plans together. In response to the challenges facing the development of private enterprises, 26 specific measures have been released in six aspects, including continuously optimizing the environment for the development of the private economy.



The conference pointed out that the private economy is an important pillar of Shanghai's development. In the new era and new journey, Shanghai is promoting high-quality development of the private economy, with strategic opportunities to accelerate the construction of the "Five Centers", strong driving force to take the lead in reform and opening up, and unique advantages to lead and connect the world. We need to elevate our political stance, strengthen our confidence and determination, and work together with private enterprises and entrepreneurs to seize the opportunity and accelerate the development of Shanghai into a new highland of private economy where innovation vitality is fully unleashed and first-class enterprises are competing to emerge. We should focus on the pain points and difficulties reflected by private enterprises, as well as the bottlenecks and blockages encountered, in order to deepen high-level reform and opening up, stimulate momentum, optimize services with a responsive and uninterrupted attitude, and pursue excellence to improve the environment, promoting the healthy and high-quality development of the city's private economy to achieve greater breakthroughs.
Xu Honglei strongly agrees with this: "The continuously optimized and upgraded legal business environment in Shanghai has given us more confidence to deeply cultivate physical industries and contribute to the cultivation of new quality productivity. We will actively respond to policy calls and help Shanghai build an innovation highland for the private economy. The '26 Measures' and' Several Measures to Promote High quality Development of the Private Economy in the New Era and New Journey 'of Shanghai's exit from Taiwan directly address the core demands of enterprise innovation and development, especially the' non prohibited entry 'market access mechanism and the' inspection code 'regulatory model, allowing enterprises to feel a more fair and transparent business environment.
We will actively respond to the call for artificial intelligence to 'mold Shanghai', rely on the advantages of Shanghai International Financial Center, increase research and development investment in the fields of intelligent supply chain and green low-carbon technology, and leverage the digital service platform built by the government to accelerate global market layout. We will build Shanghai Chaorui Group into a global marketing center, international supply chain center, and global trade headquarters for antibiotics and antipyretic analgesics, contributing wisdom and strength to the construction of a private economic innovation highland in Shanghai
The headquarters of Shanghai Chaorui Group, led by Xu Honglei, is located in the modern Xujiahui area of Shanghai. It is a well-known pharmaceutical research and development enterprise that integrates research and development, production, and sales of active pharmaceutical ingredients and drug formulations. In 2024, the total output value of Chaorui Group Corporation will exceed 1.5 billion yuan. Suzhou Fourth Pharmaceutical Factory is a holding subsidiary of Chaorui Group, specializing in the research and development of active pharmaceutical ingredients and formulations. Its flagship product, Zefen and ibuprofen capsules, is an upgraded version of ibuprofen and a new generation of anti-inflammatory, analgesic, and antipyretic drugs. Suzhou Fourth Pharmaceutical is committed to becoming a leading enterprise in the new generation of antipyretic, analgesic, and anti infective drugs.
He said that Shanghai's service philosophy of "responding to every request and not disturbing anything" and the "service package" system for key enterprises provide solid guarantees for private enterprises to focus on their main business and overcome core technologies. In the future, enterprises will deepen joint research and development with universities and research institutions, promote the cultivation of new quality productivity, and practice green supply chain social responsibility, helping to achieve the resonance between urban development and industrial upgrading.

Source:
China.com, April 15, 2025- Xu Honglei: Leveraging Digital Service Platforms to Accelerate Global Layout


< Return

Quick Contact

Adverse drug reaction feedback Hotline: 0512-52970920
Preparation Division: Manager Chen 19916769109
API Division: Manager Xu 15281069885
Sales business consultation: Manager Chen 19916769109 Email@sales@spf4.com

Scanning Code

WeCom

Wechat official account

The Little Red Book

WeCom

WeChat official account

The Little Red Book

Quick Contact

Adverse drug reaction feedback Hotline: 0512-52970920
Preparation Division: Manager Chen 19916769109
API Division: Manager Xu 15281069885
Sales business consultation: Manager Chen 19916769109 Email@sales@spf4.com

? Copyright 2024 Suzhou No.4 Pharmaceutical Factory Co., Ltd     蘇ICP備2022015841號-1     技術(shù)支持:蘇州網(wǎng)站建設(shè)

? Copyright 2024 Suzhou No.4 Pharmaceutical Factory Co., Ltd

蘇ICP備2022015841號-1   技術(shù)支持:蘇州網(wǎng)站建設(shè)